Home Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien
 

Keywords :   


Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien

2014-11-03 03:46:16| Industrial Machines - Topix.net

Conference Call Monday at 8:30 a.m. ET Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $ 700 million drug coated balloon segment COLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 -- The Spectranetics Corporation and Covidien plc today announced a definitive agreement under which Spectranetics will acquire Covidien's Stellarex drug coated angioplasty balloon platform for $30 million. The transaction is subject to approval by the Federal Trade Commission and other regulatory agencies, as well as closure of the pending acquisition of Covidien by Medtronic, which is expected to occur in early 2015.

Tags: drug assets acquire coated

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
23.11 #249
23.11muta5
23.1120
23.11BabolaT VS BUG4300 24ss
23.11
23.11 TYO26cm
23.112
23.11CW-X 2.0
More »